Kate Li

Kate Li is an accomplished biostatistician and data analytics leader with extensive experience in the pharmaceutical industry. Currently serving as Executive Director and Head of Biostatistics & Data Analytics at Anthos Therapeutics since October 2024, Kate previously held similar executive roles at Actinium Pharmaceuticals, Inc. and PTC Therapeutics, focusing on biostatistics for CNS and oncology products. Kate's earlier career includes significant contributions at Taiho Oncology as Director of statistical design for clinical trials, and at the FDA as a Mathematical Statistician, conducting reviews for numerous NDAs and BLAs. Previous positions at JPMorgan Chase, American Express, Prudential Healthcare, Roche, and Johnson & Johnson have further solidified a diverse and robust background in statistical analysis and risk management. Kate holds a PhD in Biostatistics from Columbia University, an MS in Statistics from the University at Buffalo, and a BS in Mathematics from the University of Science and Technology of China.